Mancuso Mariateresa, Pazzaglia Simonetta, Tanori Mirella, Rebessi Simonetta, Di Majo Vincenzo, Covelli Vincenzo, Saran Anna
Biotechnology Unit, ENEA Casaccia Research Center, Via Anguillarese 301, 00060 Rome, Italy.
Mutat Res. 2004 Apr 14;548(1-2):35-45. doi: 10.1016/j.mrfmmm.2003.12.017.
The two-stage skin carcinogenesis model of initiation and promotion in Carcinogenesis-susceptible (Car-S) mice has been used to investigate the pathways of promotional activity of 12-O-tetradecanoylphorbol-13-acetate (TPA), a phorbol ester tumor promoter, and benzoyl peroxide (BzPo), a free radical-generating compound. To test whether distinct populations of 9,10-dimethyl-1,2-benzanthracene (DMBA)-initiated epidermal keratinocytes are responsive to the two promoters, tandem experiments were performed. DMBA-initiated Car-S mice were promoted twice weekly with maximal promoting doses of TPA or BzPo. When the number of papillomas/mouse reached a plateau, promotion in the TPA and BzPo groups was switched to BzPo or TPA, respectively, until achievement of a new plateau. Mice promoted with BzPo developed 11.0 +/- 1.3 papillomas/mouse and subsequent TPA promotion induced 13.8 additional papillomas, for a total of 24.8 +/- 2.1 papillomas/mouse. TPA-promoted mice developed 23.3 +/- 1.1 papillomas/mouse, and subsequent BzPo promotion for 91 days did not promote additional papillomas. Our results show a less than additive tumor response after sequential promotion with BzPo and TPA, or vice versa, indicating that the pathways of promotional activity of TPA and BzPo are interacting. While the final papilloma yield was similar at the end of the two tandem promotion experiments independently of promoter sequence, the percentage of mice developing carcinomas was significantly higher in mice that were promoted with BzPo in the first stage. No significant differences in the frequency and type of c-Ha-ras mutations were observed in TPA- and BzPo-promoted tumors, suggesting that promotion of DMBA-initiated cells by BzPo requires introduction of additional molecular alterations compared to TPA.
在癌症易感性(Car-S)小鼠中采用两阶段皮肤致癌模型(启动和促进阶段),以研究佛波酯肿瘤促进剂12-O-十四烷酰佛波醇-13-乙酸酯(TPA)和自由基生成化合物过氧化苯甲酰(BzPo)的促进活性途径。为了测试不同群体的9,10-二甲基-1,2-苯并蒽(DMBA)启动的表皮角质形成细胞是否对这两种促进剂有反应,进行了串联实验。用最大促进剂量的TPA或BzPo每周两次对DMBA启动的Car-S小鼠进行促进。当每只小鼠的乳头状瘤数量达到平台期时,将TPA组和BzPo组的促进剂分别换为BzPo或TPA,直至达到新的平台期。用BzPo促进的小鼠每只产生11.0±1.3个乳头状瘤,随后用TPA促进又诱导产生13.8个乳头状瘤,每只小鼠总共产生24.8±2.1个乳头状瘤。用TPA促进的小鼠每只产生23.3±1.1个乳头状瘤,随后用BzPo促进91天未诱导产生更多乳头状瘤。我们的结果表明,先后用BzPo和TPA促进,或反之,肿瘤反应小于相加效应,这表明TPA和BzPo的促进活性途径相互作用。虽然在两个串联促进实验结束时,最终乳头状瘤产量与促进剂顺序无关,但在第一阶段用BzPo促进的小鼠中发生癌的小鼠百分比显著更高。在TPA和BzPo促进的肿瘤中,未观察到c-Ha-ras突变频率和类型的显著差异,这表明与TPA相比,BzPo促进DMBA启动的细胞需要引入额外的分子改变。